Chandramouli Nagarajan

13PUBLICATIONS
129CO-AUTHORS
Regenerative medicine (incl. stem cells)Gene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Feb 24, 2026
Early mortality with bispecific antibody therapy in RRMM: an IMWG immunotherapy database real-world analysis.

Carlyn Rose Tan, Saad Z Usmani, Andriy Derkach

|Dec 16, 2025
Daratumumab bortezomib and dexamethasone in transplant ineligible newly diagnosed elderly myeloma patients (AMN006)-a trial by Asian Myeloma Network (NCT03695744).

Melinda S Y Tan, Chandramouli Nagarajan, Melissa Ooi

|Dec 10, 2025
Venetoclax-Dexamethasone Versus Pomalidomide-Dexamethasone in t(11;14)-Positive Relapsed/Refractory Multiple Myeloma: Primary Results of the Randomized, Phase III CANOVA Study.

Rakesh Popat, Meral Beksac, Meletios A Dimopoulos

|Aug 22, 2025
Deceased donor kidney transplantation in candidates with pre-transplant hematological malignancies: a literature review and recipient allocation proposal in Singapore.

Emmett Tsz Yeung Wong, Ian Tatt Liew, Hein Than

|Jul 23, 2025
Prospective Clinical Validation of a Combinatorial Functional Precision Medicine Platform in Relapsed/Refractory Non-Hodgkin's Lymphoma.

Rui Xue Lee, Masturah Bte Mohd Abdul Rashid, Noor Rashidha Binte Meera Sahib

|Oct 17, 2024
Daratumumab-Based Therapeutic Approaches and Clinical Outcomes in Multiple Myeloma and other Plasma Cell Dyscrasias: Insights from a Nationwide Real-World Chart Review Study.

Allison C Y Tso, Wee Joo Chng, Yeow Tee Goh

Pageof 3

Frequent Collaborators

5 joint publications

Wee Joo Chng

4 joint publications

Melissa Ooi

4 joint publications

Michelle Limei Poon

3 joint publications

Yunxin Chen